Immuron

Developer of oral immunotherapy utilizing polyclonal antibody products

placeCarlton, Victoria, Australia calendar_todayFounded 1994 groups6 employees language immuron.com.au

Registered entities

Innovation

15 patent families (10 granted) — focus: Chemistry & metallurgy, Human necessities, Emerging technologies; filing pace slowing. Cited 711 times.

YearFilings
20125
20135
20146
20151
20164
20174
20183
20192
20222
20231
20251

Social engagement

Social engagement: 1.6K social following, 3 posts in the last 12 months — around the industry typical range.

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital150%
Other / undisclosed150%

Recent activity

25 Jun 2026
Product launch
IMM-529
8 May 2026
Event
Emerging Growth Conference 92
7 May 2026
Event
Emerging Growth Conference
Coming soon